LSD1-IN-43
LSD1-IN-43 is a highly selective, reversible, orally active and brain-penetrant LSD1 inhibitor with an IC50 value of 0.8 μM. LSD1-IN-43 has low inhibitory activity against MAO-A and MAO-B, two homologs of LSD1. LSD1-IN-43 significantly inhibits Aβ aggregation and enhances Aβ-induced neuronal cell viability. LSD1-IN-43 can be used for the study of Alzheimer’s disease (AD) [1].
Product Specifications
UNSPSC
12352005
Target
Amyloid-β; Histone Demethylase
Related Pathways
Epigenetics; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Smiles
C[C@@]12[C@](CC(C3=C2)=C(C)C(O3)=O)([H])C(CC4=CNC5=C4C(O)=CC=C5)C(CC1)=O
Molecular Formula
C23H23NO4
Molecular Weight
377.43
References & Citations
[1]Li Z, et al. Discovery of Atractylenolide Derivatives as Novel LSD1 Inhibitors for the Treatment of Alzheimer's Disease. J Agric Food Chem. 2025 Jun 18;73 (24) :15399-15415.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
KDM1/LSD1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15129405 1 Vial
Lentiviral mouse Nmrk2 shRNA (UAS) - Lentiviral mouse Nmrk2 shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details 